Development of monoclonal antibody-mediated interventions to combat malaria
$299,777N43FY2022AINIH
Cure Systems Llc, Newton Center MA
Investigators
Abstract
This contract is to provide proof of concept studies for the development of a vector-based delivery of a potent P. falciparum-neutralizing monoclonal antibody.
View original record on NIH RePORTER →